BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37839636)

  • 21. Krüppel-like factor 2 promotes cell proliferation in hepatocellular carcinoma through up-regulation of c-myc.
    Zou K; Lu X; Ye K; Wang C; You T; Chen J
    Cancer Biol Ther; 2016; 17(1):20-6. PubMed ID: 26853883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aurora kinase A mediates c-Myc's oncogenic effects in hepatocellular carcinoma.
    Lu L; Han H; Tian Y; Li W; Zhang J; Feng M; Li Y
    Mol Carcinog; 2015 Nov; 54(11):1467-79. PubMed ID: 25284017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma.
    Hu J; Yang L; Peng X; Mao M; Liu X; Song J; Li H; Chen F
    Hum Cell; 2022 Nov; 35(6):1838-1855. PubMed ID: 36087219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis.
    Carella A; Tejedor JR; García MG; Urdinguio RG; Bayón GF; Sierra M; López V; García-Toraño E; Santamarina-Ojeda P; Pérez RF; Bigot T; Mangas C; Corte-Torres MD; Sáenz-de-Santa-María I; Mollejo M; Meléndez B; Astudillo A; Chiara MD; Fernández AF; Fraga MF
    Int J Cancer; 2020 Jan; 146(2):373-387. PubMed ID: 31211412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
    Zhang N; Chen X
    Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An essential role of RNF187 in Notch1 mediated metastasis of hepatocellular carcinoma.
    Zhang L; Chen J; Yong J; Qiao L; Xu L; Liu C
    J Exp Clin Cancer Res; 2019 Sep; 38(1):384. PubMed ID: 31477177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axis.
    Chen Q; Yin D; Zhang Y; Yu L; Li XD; Zhou ZJ; Zhou SL; Gao DM; Hu J; Jin C; Wang Z; Shi YH; Cao Y; Fan J; Dai Z; Zhou J
    Cell Death Dis; 2017 Jun; 8(6):e2906. PubMed ID: 28661477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-22 regulating Kupffer cell polarization through STAT3/Erk/Akt crosstalk pathways to extenuate liver fibrosis.
    Su SB; Qin SY; Xian XL; Huang FF; Huang QL; ZhangDi HJ; Jiang HX
    Life Sci; 2021 Jan; 264():118677. PubMed ID: 33129875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
    Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
    Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deficiency of Tet3 in nucleus accumbens enhances fear generalization and anxiety-like behaviors in mice.
    Fan BF; Hao B; Dai YD; Xue L; Shi YW; Liu L; Xuan SM; Yang N; Wang XG; Zhao H
    Brain Pathol; 2022 Nov; 32(6):e13080. PubMed ID: 35612904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
    Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
    Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner.
    Li H; Lan T; Xu L; Liu H; Wang J; Li J; Chen X; Huang J; Li X; Yuan K; Zeng Y; Wu H
    J Exp Clin Cancer Res; 2020 Jul; 39(1):128. PubMed ID: 32631394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma.
    Yin Z; Ma T; Lin Y; Lu X; Zhang C; Chen S; Jian Z
    J Cell Biochem; 2018 Nov; 119(11):9419-9432. PubMed ID: 30015355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2.
    Chen Y; Lin C; Liu Y; Jiang Y
    Tumour Biol; 2016 Apr; 37(4):4399-408. PubMed ID: 26499944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-216b suppresses the cell growth of hepatocellular carcinoma by inhibiting Ubiquitin-specific peptidase 28 expression.
    Zhang JF
    Kaohsiung J Med Sci; 2020 Jun; 36(6):423-428. PubMed ID: 32053284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2.
    Zhu B; Sun L; Luo W; Li M; Coy DH; Yu L; Yu W
    Oncotarget; 2017 Apr; 8(14):23289-23302. PubMed ID: 28423575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PIAS-like Coactivator Zmiz1 Is a Direct and Selective Cofactor of Notch1 in T Cell Development and Leukemia.
    Pinnell N; Yan R; Cho HJ; Keeley T; Murai MJ; Liu Y; Alarcon AS; Qin J; Wang Q; Kuick R; Elenitoba-Johnson KS; Maillard I; Samuelson LC; Cierpicki T; Chiang MY
    Immunity; 2015 Nov; 43(5):870-83. PubMed ID: 26522984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma.
    Xia P; Zhang H; Xu K; Jiang X; Gao M; Wang G; Liu Y; Yao Y; Chen X; Ma W; Zhang Z; Yuan Y
    Cell Death Dis; 2021 Jul; 12(7):691. PubMed ID: 34244479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion.
    Yang J; Xing Z
    Exp Biol Med (Maywood); 2021 Sep; 246(17):1928-1937. PubMed ID: 34053234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of MEK suppresses hepatocellular carcinoma growth through independent MYC and BIM regulation.
    Zhou X; Zhu A; Gu X; Xie G
    Cell Oncol (Dordr); 2019 Jun; 42(3):369-380. PubMed ID: 30788663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.